Suchergebnisse

  • Treffer 1 - 5 von 5
Treffer weiter einschränken
  1. 1

    Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study von Sachpekidis, Christos (VerfasserIn) , Kopp-Schneider, Annette (VerfasserIn) , Hassel, Jessica C. (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) ,


    Volltext
    Article (Journal) Online Resource
  2. 2

    Imaging features of multiple myeloma extramedullary lesions in the liver with 18F-FDG PET/CT, contrast-enhanced CT and MRI von Papamichail, Dimitris (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) ,


    Volltext
    Article (Journal) Online Resource
  3. 3

    Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab von Anwar, Hoda (VerfasserIn) , Winkler, Julia K. (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Hassel, Jessica C. (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) ,


    Volltext
    Article (Journal) Online Resource
  4. 4

    Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT von Sachpekidis, Christos (VerfasserIn) , Anwar, Hoda (VerfasserIn) , Winkler, Julia K. (VerfasserIn) , Larribere, Lionel (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Hassel, Jessica C. (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) ,


    Volltext
    Article (Journal) Online Resource
  5. 5

    Can benign lymphoid tissue changes in 18F-FDG PET/CT predict response to immunotherapy in metastatic melanoma? von Sachpekidis, Christos (VerfasserIn) , Larribere, Lionel (VerfasserIn) , Hassel, Jessica C. (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) ,


    Volltext
    Article (Journal) Online Resource